ReposiTrak, Inc. entered into an Exchange Agreement with SPAR Group, Inc. and its subsidiary SPAR Marketing Force Inc. on November 13, 2026. The agreement involves the exchange of outstanding receivables and common stock holdings for Series C Convertible Preferred Stock issued by SPAR.
Under the terms of the Exchange Agreement, ReposiTrak agreed to exchange a promissory note receivable from SPAR with a principal balance of approximately $4.0 million for shares of SPAR’s Series C Convertible Preferred Stock. The preferred stock has a stated value of $1,000 per share and is convertible into common stock at a price of $0.38 per share. The preferred stock is senior to all other equity and pays cumulative dividends at an annual rate of 8%, with an additional 2% rate if dividends are paid in additional preferred shares.
In addition to the note exchange, ReposiTrak exchanged its aggregate holdings of 8,900,406 shares of SPAR common stock for 3,360 shares of Series C Preferred Stock, representing an agreed aggregate exchange value of $3,359,605. As further consideration, SPAR issued ReposiTrak a warrant to purchase an aggregate of 9,684,211 shares of common stock at an exercise price of $0.38 per share. The warrant is exercisable beginning January 31, 2028, and expires on January 31, 2032.
Both the Series C Preferred Stock and the warrant are subject to a beneficial ownership limitation. This limitation prevents the exercise or conversion of the securities if it would cause ReposiTrak’s beneficial ownership of SPAR common stock to exceed 50%. This limitation expires on December 23, 2027.
Separately, ReposiTrak entered into a Revolving Credit Agreement with SPAR on November 13, 2026. The agreement establishes a revolving credit facility with a maximum commitment of $1.5 million. The line of credit matures on November 13, 2028. Direct advances under the facility bear interest at 8% per annum, payable monthly in cash.
As part of the credit facility, SPAR is obligated to issue warrants to ReposiTrak for qualifying direct advances. These warrants have an exercise price of $0.38 per share and are not exercisable before January 31, 2028. The agreement also includes provisions for additional warrants if ReposiTrak arranges third-party financing for SPAR or its subsidiaries, known as Sourced Financing.